Forecasting

Forecasting, epidemiology, scientific, and access teams work seamlessly to produce comprehensive, defendable forecasts.

Anticipate and plan for changes in diagnosis and treatment rates, new product launches and market expansion.

Alter assumptions and add model segments while tracking patients across disease stages or lines of therapy.

Our forecasting solutions are rigorous, timely, integrated, detailed, and global. We go beyond a simple trending of prescription sales and unit volume to deliver custom market models that reflect the complexities of the market, integrate with your data sources, and support your reporting requirements.

Our staff, tools and methodologies are seamlessly linked to provide forecasting solutions that suit every market need. Our team has extensive experience with programming and advanced methodologies including volumetric forecasts, patient flow models, and cross-sectional models.

Forecasting for cancer treatments comes with unique challenges, including determining the correct number of patients, following them through lines of therapies, and addressing various biomarkers and patient segments. Our deep understanding of cancer and proprietary data solutions ensure you get a comprehensive deliverable you can trust.

We recognize the importance of rare diseases in furthering patient care and understand the inherent challenges you face. Our forecasters and epidemiologists triangulate data sources, and working with our subject matter experts, incorporate Key Opinion Leader (KOL) input to accurately size patient populations and deliver defendable forecasts.